A Prosurvival and Proangiogenic Stem Cell Delivery System to Promote Ischemic Limb Regeneration
Yanyi Xu,Minghuan Fu,Zhihong Li,Zhaobo Fan,Xiaofei Li,Anderson Peter,Liu Zhen-guo,Xie Xiao-yun,Jianjun Guan
DOI: https://doi.org/10.3389/conf.fbioe.2016.01.03035
IF: 5.7
2016-01-01
Frontiers in Bioengineering and Biotechnology
Abstract:Event Abstract Back to Event A Prosurvival and Proangiogenic Stem Cell Delivery System to Promote Ischemic Limb Regeneration Yanyi Xu1, Minghuan Fu1, 2, Zhihong Li1, 3, Zhaobo Fan1, Xiaofei Li1, Peter Anderson1, Zhenguo Liu4, Xiaoyun Xie5 and Jianjun Guan1 1 The Ohio State University, Department of Materials Science and Engineering, United States 2 Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospital, Department of Gerontology, China 3 Chenzhou First People’s Hospital, Division of General Surgery, China 4 The Ohio State University, Davis Heart and Lung Research Institute, United States 5 Tongji University, Department of Gerontology, China Introduction: Severe injuries, tissue ischemia and genetic defects impair skeletal muscle regeneration. Delivery of stem cells capable of differentiating into skeletal muscle and/or endothelial cells may facilitate the regeneration [1-3]. However, ischemic environment in the injured muscles significantly compromises the therapeutic efficacy, as cell survival and differentiation are limited in such an environment. In this work, we demonstrated that using hydrogels with prosurvival and proangiogenic factor basic fibroblast growth factor (bFGF) significantly augmented transplanted cell survival and differentiation, as well as promoted ischemic limb regeneration. Materials and Methods: Hydrogel was synthesized by free radical polymerization of N-isopropylacrylamide, 2-hydroxyethyl methacrylate, and macromer Acrylic acid-polylactide (APLA). For in vitro study, mesenchymal stem cells (MSCs, 10 million/mL) were encapsulated in the hydrogel containing bFGF (50 µg/mL) and heparin (1 mg/mL). The cells were cultured under hypoxic condition (1% O2, DMEM without FBS) for a 2-week period. Cells seeded in the hydrogel without bFGF and cultured under normal and hypoxic conditions were used as controls. For in vivo study, hindlimb ischemia was first induced in mice (aged 8 to 10 weeks) by permanent ligation of femoral artery and vein. A total of 200 µL cell delivery system was then injected into muscles (4 injection points). Treatment groups included hydrogel only, hydrogel with MSCs, and hydrogel with MSCs and bFGF. Open surgery mice were used as negative control and non-operated mice as positive control. Results and Discussion: The hydrogel had a gel-sol transition temperature around 26°C. It exhibited a Young’s modulus of 17.1± 3.4 kPa at 37oC (10% w/v in DPBS). The encapsulated bFGF was able to gradually release from hydrogel for two weeks. The released bFGF was bioactive. In vitro, the released bFGF significantly promoted MSC survival under ischemic conditions. 4 weeks after implantation, the density of surviving MSCs was significantly higher in the bFGF release group. Interestingly, some of the surviving MSCs were differentiated into skeletal muscle cells and endothelial cells and integrated with the host tissues. In addition, muscle blood perfusion was significantly improved by delivering MSCs and bFGF, with full recovery occurred after only 2 weeks of implantation. Conclusions: A thermosensitive and biodegradable hydrogel with skeletal muscle tissue-like modulus was synthesized and used to deliver bFGF and MSCs into ischemic limb. The released bFGF significantly enhanced MSC survival under ischemic conditions. The developed cell delivery system also promoted ischemic limb regeneration. References:[1] Charge SB, et al. Physiol Rev. 2004;84:209-38;[2] Carlson ME, et al. Aging Cell. 2007;6:371-82;[3] Gussoni E, et al. J Clin Invest. 2002;110:807-14. Keywords: Hydrogel, stem cell, Drug delivery, Tissue Regeneration Conference: 10th World Biomaterials Congress, Montréal, Canada, 17 May - 22 May, 2016. Presentation Type: Poster Topic: Regenerative medicine: biomaterials for control of tissue induction Citation: Xu Y, Fu M, Li Z, Fan Z, Li X, Anderson P, Liu Z, Xie X and Guan J (2016). A Prosurvival and Proangiogenic Stem Cell Delivery System to Promote Ischemic Limb Regeneration. Front. Bioeng. Biotechnol. Conference Abstract: 10th World Biomaterials Congress. doi: 10.3389/conf.FBIOE.2016.01.03035 Copyright: The abstracts in this collection have not been subject to any Frontiers peer review or checks, and are not endorsed by Frontiers. They are made available through the Frontiers publishing platform as a service to conference organizers and presenters. The copyright in the individual abstracts is owned by the author of each abstract or his/her employer unless otherwise stated. Each abstract, as well as the collection of abstracts, are published under a Creative Commons CC-BY 4.0 (attribution) licence (https://creativecommons.org/licenses/by/4.0/) and may thus be reproduced, translated, adapted and be the subject of derivative works provided the authors and Frontiers are attributed. For Frontiers’ terms and conditions please see https://www.frontiersin.org/legal/terms-and-conditions. Received: 27 Mar 2016; Published Online: 30 Mar 2016. Login Required This action requires you to be registered with Frontiers and logged in. To register or login click here. Abstract Info Abstract The Authors in Frontiers Yanyi Xu Minghuan Fu Zhihong Li Zhaobo Fan Xiaofei Li Peter Anderson Zhenguo Liu Xiaoyun Xie Jianjun Guan Google Yanyi Xu Minghuan Fu Zhihong Li Zhaobo Fan Xiaofei Li Peter Anderson Zhenguo Liu Xiaoyun Xie Jianjun Guan Google Scholar Yanyi Xu Minghuan Fu Zhihong Li Zhaobo Fan Xiaofei Li Peter Anderson Zhenguo Liu Xiaoyun Xie Jianjun Guan PubMed Yanyi Xu Minghuan Fu Zhihong Li Zhaobo Fan Xiaofei Li Peter Anderson Zhenguo Liu Xiaoyun Xie Jianjun Guan Related Article in Frontiers Google Scholar PubMed Abstract Close Back to top Javascript is disabled. Please enable Javascript in your browser settings in order to see all the content on this page.